Partners

• Charité University Medicine Berlin, Germany

• DCPrime, Netherlands

• Diagnostik Netzwerk Berlin Brandenburg - DiagnostikNet | BB, Germany

• Fasteris SA, Switzerland

• Haukeland University Hospital, Helse Bergen, Norway

• Medical University of Graz, Austria

• Natural and Medical Sciences Institute (NMI) Reutlingen, Tumor Biology, Germany

• Oceanbasis GmbH, Kiel, Germany

• Therycell GmbH, Berlin, Germany

• Technical University (TU) Berlin, Germany

• University Clinics Schleswig-Holstein, Kiel, Germany

• University Medical Clinic (UMC) Mainz, Department of Internal Medicine 3, Germany

• University Hospital Essen (UKE), Germany

• University Hospital Erlangen, Department of Internal Medicine 5 - Hematology/Oncology, Germany

 

HS Diagnomics GmbH

Schloßstrasse 110
12163 Berlin
Germany

Tel. +49(30)700 14 53 30
Fax +49(30)546 11 698

Customer Support
Tel. +49(30)700 14 53 31

News

10/2023
HSDiagnomics partners with Charité University Medicine Berlin, TheryCell GmbH, and EPO GmbH in an innovative project to advance TCR-T therapy for solid tumors
Read more ...

06/2020
TCRsafe® analysis of a Runx1 knockout mouse model provides evidence for a role of RUNX1 as a recombinase cofactor for TCRbeta rearrangements and pathological deletions
Read more ...

08/2019
ZIM-Project TCR-specific Antigen Identification - TAgID
Read more ...

04/2018
Patent granted for the identification of tumor-specific T-cell receptors
Read more ...

10/2016
Dr. Volker Lennerz joins the HSDiagnomics advisory board
Read more ...

11/2015
Patent granted for TCRsafe® analysis
Read more ...

03/2015
Prof. Dr. Armin Gerbitz joins the HSDiagnomics advisory board
Read more ...

10/2014
HSDiagnomics launches TCRsafe® T-cell profiling service
Read more ...

04/2013
HSDiagnomics wins ProFIT grant provided by Investitionsbank Berlin (IBB) 
Read more ...

04/2013
HSDiagnomics enters partnership with Charite/Berlin
Read more ...